Neovasc Inc.

Recent News

  • Neovasc Comments on Clinical Cardiology Journal Publication

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - March 2, 2021) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced that the journal Clinical Cardiology has published an article entitled, "Long-term outcomes of patients undergoing coronary sinus reducer implantation - A multicenter study."The article, authored by Maayan Konigstein, M.D., Tel Aviv Medical Center and Sackler School of Medicine, Tel Aviv University, Israel describes the long-term outcomes in 99 patients treated with the Neovasc Reducer™ ("Reducer")...

    2021-03-02 9:00 AM ET
  • Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - February 24, 2021) -  Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") has received written notification (the "Nasdaq Notice") from the Nasdaq Stock Market LLC ("Nasdaq") informing the Company that it has regained compliance with the minimum market value requirement set forth in the rules for continued listing on the Nasdaq Capital Market (the "Listing Rules").Neovasc received a letter from the Nasdaq in December 2020 notifying the Company that it...

    2021-02-24 4:05 PM ET
  • Neovasc to Participate in 10th Annual SVB Leerink Global Healthcare Conference

    Vancouver, British Columbia--(Newsfile Corp. - February 17, 2021) -  Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN), today announced that company management will be participating in the 10th Annual SVB Leerink Global Healthcare Conference that is scheduled to take place from February 24 to 26, 2021. Fred Colen, Neovasc's President and Chief Executive Officer, will present on Friday, February 26, 2021 at 1:00 pm EST.A link to the live webcast of the presentation will be available online from the investor relations section...

    2021-02-17 9:00 AM ET
  • Neovasc Announces Closing of US$72 Million Registered Direct Offering of Common Shares Priced At-The-Market

    Vancouver, British Columbia--(Newsfile Corp. - February 12, 2021) - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVCN) announced today that it has closed its previously announced sale of an aggregate of 36,000,000 common shares at a purchase price of US$2.00 per common share in a registered direct offering (the "Offering") priced at-the-market under the Nasdaq Capital Market (the "Nasdaq") rules for aggregate gross proceeds to the Company of approximately US$72 million, before deducting placement agent's fees and estimated...

    2021-02-12 3:53 PM ET
  • Neovasc Announces US$72 Million Registered Direct Offering Priced At-The-Market

    Vancouver, British Columbia--(Newsfile Corp. - February 10, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that it has entered into definitive agreements with certain healthcare-focused institutional investors for the sale of an aggregate of 36,000,000 common shares at a purchase price of US$2.00 per common share in a registered direct offering (the "Offering") priced at-the-market under the Nasdaq Capital Market (the "Nasdaq") rules for aggregate gross proceeds to the Company of approximately US$72 million,...

    2021-02-10 7:38 AM ET
  • Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - February 9, 2021) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that it has received written notification from the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) pursuant to Nasdaq Listing Rule 5810 for continued listing on the Nasdaq.Currently, the Company is still not in compliance with the minimum market...

    2021-02-09 9:00 AM ET
  • Neovasc Comments on Journal of the American Heart Association Publication

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - February 5, 2021) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced that the Journal of the American Heart Association has published an article entitled, "Angina Severity, Mortality, and Healthcare Utilization Among Veterans with Stable Angina". The prestigious journal is the official publication of the American Heart Association, and the article offers important insights into the burden of angina on both patients and healthcare systems.The article, authored by...

    2021-02-05 9:00 AM ET
  • Neovasc Announces 2021 Renewal of German Reimbursement NUB Status 1 Designation for Neovasc Reducer for Treatment of Refractory Angina

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - February 2, 2021) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced that the German Institute for the Hospital Remuneration System("InEK") has awarded the Neovasc Reducer™ ("Reducer"), a CE-Marked medical device for the treatment of refractory angina, NUB Status 1 designation once again for 2021. New examination and treatment methods (NUBs) are comprised of novel and innovative medicines, medical products and procedures that can be utili

    2021-02-02 9:32 AM ET